↓ Skip to main content

NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, September 2013
Altmetric Badge

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis
Published in
Arthritis Research & Therapy, September 2013
DOI 10.1186/ar4320
Pubmed ID
Authors

Bradley J Rabquer, Alisa E Koch

Abstract

Rheumatoid arthritis (RA) is a progressive autoimmune disease characterized by synovial membrane hyperplasia, inflammation, and angiogenesis. Hepatocyte growth factor (HGF) and its receptor, c-Met, are both overexpressed in the RA synovium. NK4 is an antagonist of HGF which has been shown to inhibit tumor growth, metastasis, and angiogenesis. In an experimental model of RA, NK4 gene therapy inhibited joint damage and inflammation in both preventative and therapeutic models. NK4 treatment therefore represents a possible therapeutic option in combating RA.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 50%
Professor > Associate Professor 1 13%
Lecturer 1 13%
Unknown 2 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 50%
Medicine and Dentistry 2 25%
Unknown 2 25%